GSH augmentation deserves investigation as a beneficial therapeutic approach for not only PD but also numerous other CNS disorders for which GSH deficiency and GSH-related enzyme deficits have been documented (multiple sclerosis, 25,26 autism, 2729 Alzheimers disease, 30,31 schizophrenia, 32,33 and bipolar disease 34 )
Nevertheless, the newly proposed regimen including vonoprazan should be evaluated in countries different from Japan in order to consider it as a global drug
Pathak K, Zhao Y, Calton EK, James AP, Newsholme P, Sherriff J, Soares MJ
Morphological changes in nerve cell bodies induced by experimental graded nerve compression
Somatostatin, the hormone that normally inhibits growth hormone release, continues functioning properly, maintaining physiological balance